LAMOLINARA, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 3.036
AS - Asia 1.779
EU - Europa 1.537
SA - Sud America 241
AF - Africa 39
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 6.637
Nazione #
US - Stati Uniti d'America 2.954
SG - Singapore 801
IT - Italia 423
CN - Cina 419
IE - Irlanda 223
VN - Vietnam 209
BR - Brasile 193
RU - Federazione Russa 181
SE - Svezia 171
DE - Germania 116
UA - Ucraina 96
GB - Regno Unito 92
IN - India 89
TR - Turchia 80
FR - Francia 53
HK - Hong Kong 47
CA - Canada 45
BD - Bangladesh 43
FI - Finlandia 39
PL - Polonia 27
NL - Olanda 24
AR - Argentina 20
ZA - Sudafrica 20
MX - Messico 19
AT - Austria 18
BE - Belgio 16
IQ - Iraq 14
CZ - Repubblica Ceca 12
JP - Giappone 12
ES - Italia 10
CL - Cile 7
PK - Pakistan 7
CO - Colombia 6
LT - Lituania 6
UZ - Uzbekistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
IL - Israele 5
KE - Kenya 5
KR - Corea 5
BG - Bulgaria 4
EG - Egitto 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
MA - Marocco 4
NP - Nepal 4
OM - Oman 4
PT - Portogallo 4
RO - Romania 4
BZ - Belize 3
CH - Svizzera 3
EC - Ecuador 3
HN - Honduras 3
PH - Filippine 3
AU - Australia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
EU - Europa 2
GR - Grecia 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
NG - Nigeria 2
NO - Norvegia 2
PE - Perù 2
SA - Arabia Saudita 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
PA - Panama 1
PR - Porto Rico 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 6.637
Città #
Singapore 640
San Jose 400
Chandler 369
Ashburn 225
Dublin 218
Jacksonville 160
Dearborn 124
Beijing 115
Ann Arbor 102
Dallas 98
Princeton 95
Council Bluffs 89
Santa Clara 80
Chieti 73
New York 70
Los Angeles 68
Ho Chi Minh City 63
The Dalles 51
Altamura 43
Nanjing 43
Hong Kong 40
Izmir 39
Hanoi 38
Boardman 35
Munich 35
Pescara 34
Wilmington 30
Redondo Beach 29
Montreal 26
Rome 23
Warsaw 23
Dong Ket 22
São Paulo 22
Buffalo 20
Moscow 20
Nanchang 20
Southend 20
Brooklyn 19
Orem 19
Cambridge 18
Chennai 17
Brussels 16
Johannesburg 15
Woodbridge 15
St Louis 14
Frankfurt am Main 13
Lappeenranta 13
Nuremberg 13
Hefei 12
Poplar 12
Pune 12
Tokyo 12
Tongling 12
Washington 12
Amsterdam 11
Da Nang 11
Denver 11
Helsinki 11
Mexico City 11
Ankara 10
Camerino 10
Castignano 10
Haiphong 10
Hebei 10
Kunming 10
Manchester 10
Milan 10
Verona 10
Vienna 10
Atlanta 9
London 9
Stockholm 9
Ancona 8
Brno 8
Houston 8
Phoenix 8
Seattle 8
Shenyang 8
Toronto 8
Bologna 7
Chicago 7
Düsseldorf 7
L’Aquila 7
Napoli 7
San Mateo 7
Tianjin 7
Turku 7
Baghdad 6
Collecorvino 6
Jiaxing 6
Macerata 6
Rouen 6
Saint-Saens 6
San Francisco 6
Mumbai 5
Nairobi 5
Rio de Janeiro 5
Santiago 5
Seoul 5
Tappahannock 5
Totale 4.212
Nome #
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 199
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 182
Retinal vascular changes and aqueous humor cytokines changes after aflibercept intravitreal injection in treatment-naïve myopic choroidal neovascularization 182
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 172
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized BALB/c mice 168
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 158
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 156
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 156
Secreted Gal-3BP is a novel promising target for non-internalizing Antibody–Drug Conjugates 151
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 150
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 147
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 143
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 139
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 137
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 137
Development of an anti-BAG3 humanized antibody for treatment of pancreatic cancer 133
Subretinal fluid levels of signal-transduction proteins and apoptosis molecules in macula-off retinal detachment undergoing scleral buckle surgery 132
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 132
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 128
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 127
Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema 127
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 126
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 123
Vitamin D3 improves the effects of low dose Der p 2 allergoid treatment in Der p 2 sensitized Balb/c mice. 119
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 118
Effects of mesenchymal stromal cells and human recombinant Nerve Growth Factor delivered by bioengineered human corneal lenticule on an innovative model of diabetic retinopathy 115
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 115
LGALS3BP antibody-drug conjugate enhances tumor-infiltrating lymphocytes and synergizes with immunotherapy to restrain neuroblastoma growth 113
Effects of GHRH Deficiency and GHRH Antagonism on Emotional Disorders in Mice 112
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 112
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 111
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 110
Multiorgan Metastasis of Human HER-2(+) Breast Cancer in Rag2(-/-);Il2rg(-/-) Mice and Treatment with PI3K Inhibitor. 105
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 103
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 103
Interleukin-15 is required for immunosurveillance and immunoprevention of HER2/neu-driven mammary carcinogenesis 101
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 101
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages 101
Deciphering the state of immune silence in fatal COVID-19 patients 101
Fatal cytokine release syndrome by an aberrant FLIP/STAT3 axis 101
Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis 101
Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment 100
Interrupting the nitrosative stress fuels tumor-specific cytotoxic T lymphocytes in pancreatic cancer 98
HER2-Displaying M13 Bacteriophages induce Therapeutic Immunity against Breast Cancer 96
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancer 96
The SRCIN1/p140Cap adaptor protein negatively regulates the aggressiveness of neuroblastoma 95
p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response 93
Natural compounds, antioxidant, and antiandrogens in the prevention of prostate cancer: in vivo evidences from murine models and human clinical studies. 86
Evaluation of Antibody-Drug Conjugate Performances Using a Novel HPLC-DAD Method for Tumor-Specific Detection of DM4 and S-Methyl-DM4 83
EV20/Omomyc: A novel dual MYC/HER3 targeting immunoconjugate 82
Development of a vlp-based vaccine displaying an XCT extracellular domain for the treatment of metastatic breast cancer 81
The specific deletion of cyclooxygenase-1 in megakaryocytes/platelets reduces intestinal polyposis in ApcMin/+ mice 77
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 76
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors 75
Pyrvinium Pamoate Induces Death of Triple-Negative Breast Cancer Stem-Like Cells and Reduces Metastases through Effects on Lipid Anabolism 72
Independent prognostic and predictive role of interstitial macrophages in kidney biopsies of IgA nephropathy patients 72
Pancreatic beta-cell specific BAG3 knockout results in chronic hyperinsulinemia inducing insulin resistance 71
Improvement of urinary tract symptoms and quality of life in benign prostate hyperplasia patients associated with consumption of a newly developed whole tomato-based food supplement: a phase II prospective, randomized double-blinded, placebo-controlled study 69
Duality of Nrf2 in iron-overload cardiomyopathy 60
null 52
IL-7 promotes the formation of DNA double strand breaks and DNA repair in murine pro-B cells 48
Feasibility Study of Decellularized Corneal Lenticule in a Porcine Model for Macular Hole Closure 21
Liver-specific BAG3 knockout delays chemically induced hepatocellular carcinoma development 7
Systemic AAV8-SIL1-TAT therapy improves motor function in a mouse model of Marinesco-Sjögren syndrome 5
Tumor microenvironment remodeling by STING agonism sensitizes endothelial cells to cytotoxic anti-PD-L1/L2 antibody 2
Totale 6.964
Categoria #
all - tutte 27.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202141 0 0 0 0 0 0 0 0 0 0 0 41
2021/2022294 7 12 6 63 12 3 8 29 19 11 26 98
2022/2023931 75 137 69 111 85 155 41 77 106 8 35 32
2023/2024448 30 22 28 23 26 132 95 24 8 16 4 40
2024/20251.268 58 262 209 56 33 69 58 91 117 69 144 102
2025/20262.746 182 84 218 324 333 178 485 117 262 286 160 117
Totale 6.964